Effectiveness of omalizumab as treatment of allergic pulmonary aspergillosis in patients with cystic fibrosis and asthma

Med Clin (Barc). 2022 Aug 12;159(3):e21-e22. doi: 10.1016/j.medcli.2022.02.008. Epub 2022 May 27.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Aspergillosis, Allergic Bronchopulmonary* / complications
  • Aspergillosis, Allergic Bronchopulmonary* / drug therapy
  • Asthma* / complications
  • Asthma* / drug therapy
  • Cystic Fibrosis* / complications
  • Humans
  • Omalizumab / therapeutic use
  • Treatment Outcome

Substances

  • Omalizumab